v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income $ 7,349 $ 9,939
Adjustments to reconcile net income to cash provided by operating activities:    
Amortization expense 1,004 874
Amortization of deferred financing costs 90 109
Share-based compensation 6,877 84
Deferred income taxes 9 (3)
(Increase) decrease in operating assets:    
Commissions and fees receivable (652) 122
Income tax receivable 1,150 0
Prepaid expenses and other current assets 73 (114)
Increase (decrease) in operating liabilities:    
Accounts payable (1,452) (1,480)
Commissions payable 872 1,323
Income tax payable 1,548 3,411
Accrued expenses (177) 50
Net cash provided by operating activities 16,691 14,315
Cash flows from investing activities:    
Internally developed software (1,096) (910)
Net cash used in investing activities (1,096) (910)
Cash flows from financing activities:    
Change in fiduciary receivables (728) (1,007)
Change in fiduciary liabilities 18,068 16,230
Repayments of 2024 Term Loan 0 (4,000)
Repayments of revolving credit facility (13,000) 0
Proceeds from exercise of stock options 1,047 0
Taxes paid related to net share settlement of equity awards (1,136) 0
Net cash provided by financing activities 4,251 11,223
Net increase in cash and cash equivalents and fiduciary cash 19,845 24,628
Cash and cash equivalents and fiduciary cash:    
Beginning of period 40,549 28,065
End of period 60,394 52,693
Cash and cash equivalents 10,542 16,499
Fiduciary cash 49,852 36,194
Total cash and cash equivalents and fiduciary cash $ 60,394 $ 52,693